专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2008020975A3 DEVICES AND METHODS FOR ATRIAL APPENDAGE EXCLUSION 审中-公开
标题翻译：用于ATRIAL附录排除的装置和方法
公开(公告)号：WO2008020975A3
公开(公告)日：2008-10-30
申请号：PCT/US2007016824
申请日：2007-07-26
申请人： CARDIOTHORACIC SYS INC , CHIN ALBERT K , DAVID JOHN W , SHROFF KETAN , AGARWAL AMIT , UEMURA SHUJI , CANTU ALFREDO R , WILLIS GEOFFREY H , CALLAS PETER , GRESL CHARLES
发明人： CHIN ALBERT K , DAVID JOHN W , SHROFF KETAN , AGARWAL AMIT , UEMURA SHUJI , CANTU ALFREDO R , WILLIS GEOFFREY H , CALLAS PETER , GRESL CHARLES
IPC分类号： A61B1/00
CPC分类号： A61B17/122 , A61B17/064 , A61B17/0643 , A61B17/068 , A61B17/1227 , A61B2017/00243 , A61B2017/0647 , A61B2017/0649 , A61B2017/1225
摘要： Devices, tools and methods for occluding fluid flow between two walls of tissue in a patient. Two walls of tissue are compressed together with sufficient compressive force to prevent fluid flow between the two walls, while ensuring that the compressive force is not so great as to cause tissue necrosis. The devices, tools and methods may be carried out using minimally invasive surgical techniques, such as in reduced-access surgical sites. Devices, tools and methods are provided for occluding an atrial appendix.
摘要翻译：用于阻塞患者组织的两个壁之间的流体流动的装置，工具和方法。组织的两个墙壁以足够的压缩力被压缩在一起，以防止两个壁之间的流体流动，同时确保压缩力不会大到导致组织坏死。装置，工具和方法可以使用微创手术技术进行，例如在减少手术部位。提供了用于阻塞心房附件的装置，工具和方法。

2. 发明申请

WO2008042034A2 APPARATUS AND METHODS FOR PERFORMING MINIMALLY-INVASIVE SURGICAL PROCEDURES 审中-公开
标题翻译：用于执行最小的外科手术的装置和方法
公开(公告)号：WO2008042034A2
公开(公告)日：2008-04-10
申请号：PCT/US2007016811
申请日：2007-07-26
申请人： CARDIOTHORACIC SYS INC , KENDALE AMAR , PEREZ JUAN I , VILLAGOMEZ FRED , BARRIGAR FREDERICK , LAMBERTI JOSEPH N , AGARWAL AMIT , CALLAS PETER , STEWART MICHAEL C , LIN ARTHUR , ABBOTT RYAN , CANTU ALFREDO R
发明人： KENDALE AMAR , PEREZ JUAN I , VILLAGOMEZ FRED , BARRIGAR FREDERICK , LAMBERTI JOSEPH N , AGARWAL AMIT , CALLAS PETER , STEWART MICHAEL C , LIN ARTHUR , ABBOTT RYAN , CANTU ALFREDO R
IPC分类号： A61B18/14 , A61B5/04
CPC分类号： A61B17/32 , A61B1/00096 , A61B1/00101 , A61B1/0125 , A61B1/018 , A61B1/313 , A61B17/3421 , A61B17/3478 , A61B18/18 , A61B2017/00243 , A61B2017/320044 , A61B2017/3445 , A61B2017/3456
摘要： Devices, tools and methods for performing minimally invasive surgical procedures. Methods of performing minimally invasive ablation procedures. Methods of performing rapid exchange of tools in a device while the device remains in a reduced-access surgical space.
摘要翻译：用于执行微创外科手术的装置，工具和方法。执行微创消融手术的方法。在设备保持在缩小的手术空间中时，在设备中执行工具的快速交换的方法。

3. 发明申请

WO2006127238A3 APPARATUS AND METHODS FOR PERFORMING ABLATION 审中-公开
标题翻译：用于执行消除的装置和方法
公开(公告)号：WO2006127238A3
公开(公告)日：2007-12-21
申请号：PCT/US2006017455
申请日：2006-05-04
申请人： CARDIOTHORACIS SYSTEMS INC , CHIN ALBERT K , WILLIS GEOFFREY H , UEMURA SHUJI , CANTU ALFRED R , JAVIER MANUEL A JR , JOHNSON THEODORE C , AGARWAL AMIT
发明人： CHIN ALBERT K , WILLIS GEOFFREY H , UEMURA SHUJI , CANTU ALFRED R , JAVIER MANUEL A JR , JOHNSON THEODORE C , AGARWAL AMIT
IPC分类号： A61B18/18 , A61N1/00
CPC分类号： A61B1/313 , A61B1/00096 , A61B1/00101 , A61B18/18 , A61B2017/00243
摘要： Apparatus and methods for performing endoscopic surgical procedures where only a minimal number of (or even one) openings are required to perform the procedures. Ablation procedures, including epicardial ablation procedures and apparatus for performing such procedures. Epicardial atrial ablation may be performed epicardially with access through only one side of a patient's chest required to perform all procedures.
摘要翻译：用于执行内窥镜外科手术的装置和方法，其中只需要最少数量（或甚至一个）开口来执行手术。消融手术，包括心外膜消融手术和执行此类手术的装置。心外膜心房消融可以进行心外膜，仅通过患者胸部的一侧进行，以执行所有手术。

4. 发明申请

WO2007111758A3 APPARATUS AND METHODS FOR CARDIAC ABLATION 审中-公开
标题翻译：装置和方法用于心脏衰竭
公开(公告)号：WO2007111758A3
公开(公告)日：2008-02-21
申请号：PCT/US2007000260
申请日：2007-01-04
申请人： AFX INC , SHROFF KETAN , CHIN SING FATT , AGARWAL AMIT , MORIN PATRICK
发明人： SHROFF KETAN , CHIN SING FATT , AGARWAL AMIT , MORIN PATRICK
IPC分类号： A61B18/04 , A61B18/18
CPC分类号： A61B18/1442 , A61B18/18 , A61B2017/00084 , A61B2017/2945 , A61B2018/00363 , A61B2018/00375 , A61B2018/00809 , A61B2018/1432
摘要： An adjustable surgical clamp including one or more ablation elements creates a circular lesion in a first operating mode and a linear lesion in a second operating mode. A "box" lesion surrounding all four pulmonary veins may be formed by using the clamp to create two complimentary C-shaped lesions about pairs of the veins. A thermochromic liquid crystal strip that changes color at a tissue-ablating threshold temperature may be mounted on the surgical clamp to monitor temperature of the ablated tissue. Two microwave antennae may be positioned on the jaws of the clamp relative to each other to produce a combined substantially uniform field of tissue-ablating energy between the jaws.
摘要翻译：包括一个或多个消融元件的可调节手术夹具在第二操作模式中产生在第一操作模式中的圆形损伤和线性损伤。围绕所有四个肺静脉的“盒”病变可以通过使用夹具形成关于静脉对的两个互补的C形损伤来形成。在组织消融阈值温度下改变颜色的热致变色液晶条可以安装在外科夹具上以监测烧蚀组织的温度。两个微波天线可以相对于彼此定位在夹钳的钳口上，以在钳口之间产生组合的基本均匀的组织消融能量场。

5. 发明申请

WO2009145990A2 MULTI-TIER SECURITY EVENT CORRELATION AND MITIGATION 审中-公开
标题翻译：多层次安全事件相关和缓解
公开(公告)号：WO2009145990A2
公开(公告)日：2009-12-03
申请号：PCT/US2009038293
申请日：2009-03-25
申请人： AVAYA INC , AGARWAL AMIT , AHRENS DAVID , LIVINGOOD ROD , MANI MAHALINGAM , SINGH NAVJOT , ZMOLEK ANDREW
发明人： AGARWAL AMIT , AHRENS DAVID , LIVINGOOD ROD , MANI MAHALINGAM , SINGH NAVJOT , ZMOLEK ANDREW
IPC分类号： G06F21/00 , G06F15/16
CPC分类号： G06F21/554 , H04L63/1425
摘要： The present invention is directed to the use of a multi-tiered security architecture that includes vendor-operated global security services and policy servers able to exchange security events and mitigation measures.
摘要翻译：本发明涉及使用包括供应商操作的全球安全服务和能够交换安全事件和缓解措施的策略服务器的多层安全架构。

6. 发明申请

WO2008073856A3 DELIVERY OF NANOPARTICLES AND/OR AGENTS TO CELLS 审中-公开
标题翻译：将纳米颗粒和/或细胞递送到细胞
公开(公告)号：WO2008073856A3
公开(公告)日：2009-05-07
申请号：PCT/US2007086880
申请日：2007-12-07
申请人： MASSACHUSETTS INST TECHNOLOGY , UNIV CALIFORNIA SAN DIEGO , BHATIA SANGEETA N , HARRIS TODD , AGARWAL AMIT , MIN DAL-HEE , DERFUS AUSTIN M , VON MALTZAHN GEOFFREY
发明人： BHATIA SANGEETA N , HARRIS TODD , AGARWAL AMIT , MIN DAL-HEE , DERFUS AUSTIN M , VON MALTZAHN GEOFFREY
IPC分类号： A61K48/00 , A61K41/00 , A61K47/48 , A61K49/00
CPC分类号： B82Y5/00 , A61K47/62 , A61K47/6923 , A61K49/0067
摘要： The present invention provides systems, methods, and compositions for targeted delivery of nanoparticles and/or agents to tissues, cells, and/or subcellular locales. In general, compositions comprise a nanoparticle (e.g. quantum dot, polymeric particle, etc.), at least one modulating entity (such as a targeting moiety, transfection reagent, protective entity, etc.), and at least one agent to be delivered (e.g. therapeutic, prophylactic, and/or diagnostic agent). The present invention provides methods of making and using nanoparticle entities in accordance with the present invention.
摘要翻译：本发明提供用于将组织，细胞和/或亚细胞区域的纳米颗粒和/或试剂靶向递送的系统，方法和组合物。通常，组合物包含纳米颗粒（例如量子点，聚合物颗粒等），至少一个调节实体（例如靶向部分，转染试剂，保护性实体等）和至少一种待递送的试剂（例如治疗，预防和/或诊断试剂）。本发明提供了制备和使用根据本发明的纳米颗粒实体的方法。

7. 发明申请

WO2008051522A2 A METHOD AND APPARATUS FOR RESPONSE ENABLED MESSAGING 审中-公开
标题翻译：一种用于响应消息传递的方法和装置
公开(公告)号：WO2008051522A2
公开(公告)日：2008-05-02
申请号：PCT/US2007022437
申请日：2007-10-22
申请人： VERISIGN INC , EASWAR VENKAT , AGARWAL AMIT , CHOWDHURY PARTHA , BAKSHI CHIRAG
发明人： EASWAR VENKAT , AGARWAL AMIT , CHOWDHURY PARTHA , BAKSHI CHIRAG
IPC分类号： H04Q7/20
CPC分类号： H04L51/02 , H04L12/1836 , H04L51/16 , H04L51/18 , H04L51/38
摘要： A method and apparatus for creating associations between messages in a stateless system. The method comprises adding a unique identification to a notification message at a gateway, and upon receiving a response from a user, identifying the unique identification within the response, and utilizing the unique identification to associate the response with the notification message.
摘要翻译：一种在无状态系统中创建消息之间的关联的方法和装置。该方法包括在网关处向通知消息添加唯一标识，以及在接收到来自用户的响应时，识别响应内的唯一标识，以及利用唯一标识将响应与通知消息相关联。

8. 发明申请

WO2010070672A3 PHYTOCHEMICAL COMPOSITION COMPRISING CAFEIC ACID DERIVATIVES 审中-公开
标题翻译：包含乳酸衍生物的生物化学组合物
公开(公告)号：WO2010070672A3
公开(公告)日：2010-09-16
申请号：PCT/IN2009000682
申请日：2009-11-25
申请人： AGARWAL AMIT
发明人： AGARWAL AMIT
IPC分类号： A61K36/484 , A61K31/216 , A61P1/00
CPC分类号： A61K31/216 , A61K31/192 , A61K31/352 , A61K31/353 , A61K31/704 , A61K36/484 , A61K45/06 , A61K2300/00
摘要： The present invention is successful in providing caffeic acid derivatives namely eicosanyl caffeate and docosyl caffeate from Glycyrrhiza. Also, the present invention provides a composition comprising said bio actives and also provides a process to prepare the composition. Ultimately, the invention provides solution for the management of ulcer.
摘要翻译：本发明成功地提供咖啡酸衍生物，即来自甘草的咖啡酸二十烷基酯和咖啡酸二十二烷酸酯。此外，本发明提供了包含所述生物活性物质的组合物，并且还提供了制备组合物的方法。最终，本发明提供了治疗溃疡的解决方案。

9. 发明申请

WO2007141807A2 A SYNERGISTIC HERBAL COMPOSITION FROM BACOPA SPECIES FOR MANAGEMENT OF NEURODEGENERATIVE DISORDERS AND A PROCESS OF PREPARATION THEREOF 审中-公开
标题翻译：来自BACOPA物种的协同草本组合物用于管理神经损伤性病症及其制备方法
公开(公告)号：WO2007141807A2
公开(公告)日：2007-12-13
申请号：PCT/IN2007000224
申请日：2007-06-05
申请人： AGARWAL AMIT
发明人： AGARWAL AMIT
IPC分类号： A61K9/50 , A61K33/26
CPC分类号： A61K31/353 , A61K36/80 , A61K45/06 , A61K2300/00
摘要： The present invention relates to a potent synergistic herbal composition [BacoMind®] from the plant species Bacopa monnieri and its beneficial effects in learning, memory ,cognition and Attention Deficit Hyperactivity Disorder [ADHD] or Attention Deficit Disorder [ADD]. In addition, the present invention provides the synergistic composition derived from Bacopa monnieri such that the resulting composition consists of Bacoside A3 in the range of 0.1 to 25%, Bacopaside II in the range of 0.1 to 25%, Jujubogenin isomer of bacopasaponin C in the range of 0.1 to 25%, Bacopasaponin C in the range of 0.1 to 25%, Bacopaside I in the range of 0.1 to 25%, Bacosine in the range of 0.1 to 25%, Apigenin in the range of 0.05 to 5%, Luteolin in the range of 0.05 to 5% and Sitosterol-D-glucoside in the range of 0.05 to 5% constituting up to 50% by weight of the total composition.
摘要翻译：本发明涉及来自植物种Bacopa monnieri的有效的协同草药组合物及其在学习，记忆，认知和注意缺陷多动障碍[ADHD]或注意力缺陷障碍[ADD]中的有益效果。此外，本发明提供了衍生自Bacopa monnieri的协同组合物，使得得到的组合物由0.1至25％的Bacoside A3，0.1至25％范围内的Bacopaside II组成，Bacopasaponin C中的Jujubogenin异构体范围为0.1〜25％，Bacopasaponin C为0.1〜25％，Bacopaside I为0.1〜25％，Bacosine为0.1〜25％，芹菜素为0.05〜5％，木犀草素在0.05至5％的范围内，而甾醇-D-葡萄糖苷的含量在0.05至5％的范围内，构成总组合物的50重量％。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式